Champions Oncology, Inc.
CSBR
$7.05
-$0.02-0.28%
NASDAQ
| 10/31/2025 | 07/31/2025 | 04/30/2025 | 01/31/2025 | 10/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 161.24% | 76.24% | -140.82% | 517.45% | -44.55% |
| Total Depreciation and Amortization | -0.28% | -9.14% | -1.01% | -0.25% | -11.14% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 34.86% | -17.70% | 13.23% | 446.81% | -80.25% |
| Change in Net Operating Assets | -1,610.05% | -97.42% | 257.15% | -226.93% | 21.95% |
| Cash from Operations | -389.17% | -91.26% | 1,301.63% | 273.14% | -191.00% |
| Capital Expenditure | -426.09% | 81.82% | -502.38% | 55.32% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -426.09% | 81.82% | -502.38% | 55.32% | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -2.63% | 0.00% | 0.00% | -2.70% | 0.00% |
| Issuance of Common Stock | 762.50% | 300.00% | -84.21% | -86.23% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 1,300.00% | 56.25% | -- | -100.00% | 745.95% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -435.00% | -91.80% | 1,369.42% | 424.64% | -150.36% |